Literature DB >> 20227612

Avastin as monotherapy for retinopathy of prematurity.

Helen A Mintz-Hittner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20227612     DOI： 10.1016/j.jaapos.2009.12.002

Source DB:  PubMed          Journal:  J AAPOS        ISSN： 1091-8531            Impact factor:   1.220


× No keyword cloud information.
  12 in total

1.  Clinical Management of Recurrent Retinopathy of Prematurity after Intravitreal Bevacizumab Monotherapy.

Authors:  Helen A Mintz-Hittner; Megan M Geloneck; Alice Z Chuang
Journal:  Ophthalmology       Date:  2016-05-27       Impact factor: 12.079

Review 2.  Educational paper: Retinopathy of prematurity.

Authors:  Ingele Casteels; Catherine Cassiman; Joachim Van Calster; Karel Allegaert
Journal:  Eur J Pediatr       Date:  2011-11-04       Impact factor: 3.183

3.  Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity.

Authors:  Helen A Mintz-Hittner; Kathleen A Kennedy; Alice Z Chuang
Journal:  N Engl J Med       Date:  2011-02-17       Impact factor: 91.245

Review 4.  The role of anti-vascular endothelial growth factor in treatment of retinopathy of prematurity-a current review.

Authors:  Shing Chuen Chow; Pun Yuet Lam; Wai Ching Lam; Nicholas Siu Kay Fung
Journal:  Eye (Lond)       Date:  2022-01-11       Impact factor: 4.456

5.  Adjunctive effect of intravitreal bevacizumab prior to lens-sparing vitrectomy in aggressive posterior retinopathy of prematurity: a case report.

Authors:  Hae Jung Sun; Kyung Seek Choi; Sung Jin Lee
Journal:  Jpn J Ophthalmol       Date:  2012-07-28       Impact factor: 2.447

6.  Treatment of retinopathy of prematurity: a review of conventional and promising new therapeutic options.

Authors:  Fatih Mehmet Mutlu; Serdar Umit Sarici
Journal:  Int J Ophthalmol       Date:  2013-04-18       Impact factor: 1.779

7.  Refractive status of Chinese with laser-treated retinopathy of prematurity.

Authors:  Lu Ruan; Hai-Dong Shan; Xing-Zong Liu; Xin Huang
Journal:  Optom Vis Sci       Date:  2015-04       Impact factor: 1.973

8.  Outcomes and Prognostic Factors of Intravitreal Bevacizumab Monotherapy in Zone I Stage 3+ and Aggressive Posterior Retinopathy of Prematurity.

Authors:  Simona Delia Nicoară; Constanța Nascutzy; Cristina Cristian; Iulian Irimescu; Anne Claudia Ștefănuț; Gabriela Zaharie; Tudor Drugan
Journal:  J Ophthalmol       Date:  2015-09-27       Impact factor: 1.909

9.  Asymmetric Outcomes of Type 1 Retinopathy of Prematurity after Bilateral Intravitreal Ranibizumab Treatment.

Authors:  Qiujing Huang; Qi Zhang; Yu Xu; Xunda Ji; Ping Fei; Jie Peng; Yi-An Li; Peiquan Zhao
Journal:  J Ophthalmol       Date:  2017-03-29       Impact factor: 1.909

10.  Intravitreally Injected Anti-VEGF Antibody Reduces Brown Fat in Neonatal Mice.

Authors:  Dong Hyun Jo; Sung Wook Park; Chang Sik Cho; Michael B Powner; Jin Hyoung Kim; Marcus Fruttiger; Jeong Hun Kim
Journal:  PLoS One       Date:  2015-07-30       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.